A woman is taking legal action after suffering an eye injury that she claims was caused by a bladder drug. The drug, Elmiron, is made and sold by a subsidiary of Johnson & Johnson.

Elmiron is the only FDA-approved medication for treating cystitis, a bladder condition that causes lower abdominal pain and a frequent need to urinate.  It’s also known as painful bladder syndrome and bladder pain syndrome.

The woman filing suit says that her vision started to decline about six years after she started taking the drug. Doctors diagnosed her with maculopathy, a retinal disease that can lead to blindness.

Warnings on Elmiron bottles outline the possible side effects and rare visual complications from using the drug, but they don’t mention maculopathy. The plaintiff Johnson & Johnson Elmiron lawsuit says that this misinformation makes J&J liable for the woman’s injuries.

Janssen Pharmaceuticals, the maker of the bladder medication, has sold the drug for more than two decades. Despite thousands of other lawsuits Johnson & Johnson has faced over the years, this is the first time Elmiron has been the subject of legal injury claims.

Preliminary investigations have found that at least 100 other Elmiron consumers have lost their vision as a result of taking the drug. The manufacturers have not declared vision loss as a side effect of Elmiron, nor have they made a statement about the incoming lawsuits.

The Johnson & Johnson Elmiron lawsuit alleges that the company had knowledge of the serious health risks but chose not to disclose them. If you or someone you know has suffered a visual problem after taking Elmiron, contact TorHoerman Law to see if you’re eligible for a Johnson & Johnson Elmiron lawsuit.



One of our associates will follow up with you shortly